Regimen-related toxicity in patients undergoing bone marrow transplantation.
- 1 October 1988
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 6 (10), 1562-1568
- https://doi.org/10.1200/jco.1988.6.10.1562
Abstract
Bone marrow transplantation is associated with significant morbidity and mortality, some of which is due to high-dose chemoradiotherapy. In order to quantitate toxicity that was felt to be due to the preparative regimen (termed regimen-related toxicity [RRT]), a system was developed in which toxicities were graded from 0 (none) to 4 (fatal). One hundred ninety-five patients who underwent marrow transplantation for leukemia were studied retrospectively to determine whether toxicities that were clinically felt to be due to the preparative regimen were influenced by other factors such as disease status, graft-versus-host disease (GVHD) prophylaxis, and allogenicity. All patients developed grade I toxicity in at least one organ, and 30 developed grades III-IV (life-threatening or fatal) RRT. RRT was more common in relapsed patients v remission patients (P = .04), in those receiving 15.75 Gy total body irradiation (TBI) v 12.0 Gy TBI (P = .028), and in those receiving allogeneic marrow v autologous marrow (P =...This publication has 11 references indexed in Scilit:
- Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemiaBlood, 1985
- Oral manifestations of bone marrow transplantationAmerican Journal of Clinical Oncology, 1985
- MARROW TRANSPLANTATION FOR CHRONIC MYELOCYTIC-LEUKEMIA - A CONTROLLED TRIAL OF CYCLOSPORINE VERSUS METHOTREXATE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE1985
- Bone Marrow Transplantation or Chemotherapy After Remission Induction for Adults with Acute Nonlymphoblastic LeukemiaAnnals of Internal Medicine, 1984
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984
- Nephrotoxicity in bone marrow transplant recipients treated with cyclpsporin ABritish Journal of Haematology, 1983
- ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATIONTransplantation, 1983
- TREATMENT OF CHRONIC GRANULOCYTIC LEUKAEMIA IN CHRONIC PHASE BY ALLOGENEIC MARROW TRANSPLANTATIONThe Lancet, 1982
- NONBACTERIAL NONFUNGAL PNEUMONIA FOLLOWING MARROW TRANSPLANTATION IN 100 IDENTICAL TWINSTransplantation, 1982
- MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION1979